"Another thing that I wanted to bring up, that many of you have maybe not thought about, but I have heard repeatedly in my circles is the issue of immunogenicity of phylomers. I mean they are taking large peptides 28-40mers, and those are their phylomers that they are identifying from these libraries."
BioExec: Have you ignored the possibility of Pharma partners working with smaller derivatives of PYCs peptides?
SoT
Ann: Core patent granted in Australia , page-32
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |